Pulmonary Mycobacterium abscessus infection treated in combination with inhaled tigecycline

被引：1

作者：

Pedersen, Andreas Arnholdt ^{[1
,2
,3
]}

Floe, Andreas ^{[4
]}

Lokke, Anders ^{[1
,2
]}

Hilberg, Ole ^{[1
,2
,3
]}

机构：

[1] Lillebaelt Hosp, Dept Pulm Res, Vejle, Denmark

[2] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark

[3] Mycobacterial Ctr Res Southern Denmark, Odense, Denmark

[4] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark

来源：

BMJ CASE REPORTS | 2023年 / 16卷 / 12期

关键词：

Infectious diseases; TB and other respiratory infections; Respiratory medicine; Drugs: infectious diseases; DISEASE;

D O I：

10.1136/bcr-2023-255383

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary disease caused by Mycobacterium abscessus is difficult to treat, as there is currently no reliable evidence-based treatment. Treatment is long, complex and has many side effects. In this case, we report a patient with treatment-refractory pulmonary M. abscessus disease, treated with inhaled tigecycline. Treatment with inhaled tigecycline lasted 15 months with comparably limited side effects. There were no positive mycobacterial cultures in the follow-up period of 2 years. Inhaled tigecycline is an option in the treatment of pulmonary M. abscessus when first-line treatment fails. Additional research should investigate this further.

引用

页数：4

共 50 条

[1] Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
Pearce, Camron
Ruth, Mike M.
Pennings, Lian J.
Wertheim, Heiman F. L.
Walz, Amanda
Hoefsloot, Wouter
Ruesen, Carolien
Munoz Gutierrez, Juan
Gonzalez-Juarrero, Mercedes
van Ingen, Jakko
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1889 - 1894
[2] Teicoplanin - Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
Aziz, Dinah B.
Teo, Jeanette W. P.
Dartois, Veronique
Dick, Thomas
FRONTIERS IN MICROBIOLOGY, 2018, 9
[3] Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease
Ferro, Beatriz E.
Srivastava, Shashikant
Deshpande, Devyani
Pasipanodya, Jotam G.
van Soolingen, Dick
Mouton, Johan W.
van Ingen, Jakko
Gumbo, Tawanda
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 2895 - 2900
[4] Outcomes of pulmonary Mycobacterium abscessus infection
Flight, William G.
Hough, Natasha E.
Chapman, Stephen J.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2020, 9 (01) : 48 - 52
[5] Inhaled tigecycline induces change in immune cell modulation that synergizes with antimicrobial activity in chronic pulmonary Mycobacterium abscessus disease
Pearce, Camron M.
Walz, Amanda
Gonzalez-Juarrero, Mercedes
Ali, Zohaib
Munoz-Gutierrez, Juan
van Ingen, Jakko
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[6] An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
Sun, Yan
Zhang, Kaixi
Santos, May Delos
Pee, Carmen J. E.
Yang, Yanmeng
Kang, Meiqi
Shin, Sung Jae
Chan-Park, Mary B.
Pethe, Kevin
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (08)
[7] Atypical Presentation of Mycobacterium Abscessus Pulmonary Infection
Marmor, M.
Hazard, F.
Ruoss, S. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[8] Pulmonary Mycobacterium abscessus Infection: A Pathogen in Disguise
Waugh, Kiersten M.
Wajahat, Rana
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
[9] Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection
Ferro, Beatriz E.
Srivastava, Shashikant
Deshpande, Devyani
Pasipanodya, Jotam G.
van Soolingen, Dick
Mouton, Johan W.
van Ingen, Jakko
Gumbo, Tawanda
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6374 - 6376
[10] Efficacy and safety of tigecycline for Mycobacterium abscessus disease
Kwon, Yong-Soo
Levin, Adrah
Kasperbauer, Shannon H.
Huitt, Gwen A.
Daley, Charles L.
RESPIRATORY MEDICINE, 2019, 158 : 89 - 91

← 1 2 3 4 5 →